GoTo Telemed, the nation's leading integrated telehealth ecosystem serving over 10 million patients nationwide , today announced the launch of its dedicated Hyperbilirubinemia Follow-up Program, a comprehensive virtual care service designed to transform post-discharge monitoring for newborns with jaundice. The program combines nurse-led home visits, transcutaneous bilirubin (TcB) screening, and real-time pediatric teleconsultation to ensure safe, effective management of neonatal jaundice while eliminating unnecessary hospital readmissions and reducing stress for new families .

Neonatal jaundice affects approximately 60% of term and 80% of preterm infants in the first week of life, making it one of the most common postnatal conditions requiring medical attention . While most cases are benign physiologic jaundice, severe hyperbilirubinemia can lead to bilirubin neurotoxicity and, in rare cases, permanent brain damage known as kernicterus . The critical window for monitoring occurs after hospital discharge, when bilirubin levels typically peak between 3 to 5 days of life—precisely when new parents are home without medical support .

"For new parents, the transition home with a jaundiced newborn creates immense anxiety. Is the yellow color getting worse? Is the baby feeding enough? When should we worry?" said a GoTo Telemed spokesperson. "Our Hyperbilirubinemia Follow-up Program replaces guesswork with precision. We bring objective bilirubin measurement directly to the home, connect families to pediatric specialists in real time, and provide clear, evidence-based guidance—all while eliminating the need for stressed parents to pack up a newborn for repeat trips to the doctor's office or emergency room."

Evidence-Based Model Proven to Reduce Unnecessary Referrals

GoTo Telemed's program is built on a robust clinical evidence base demonstrating the safety and efficacy of telehealth-enabled jaundice management. A landmark 2026 study published in Neonatology evaluating a nurse-led home pathway integrating transcutaneous bilirubin screening with targeted pediatric teleconsultation found dramatic improvements in care delivery :

81.9% reduction in neonatal referrals for jaundice evaluation, eliminating unnecessary visits while maintaining perfect safety

0.4% of infants required phototherapy, all of whom were identified through the program within 14 days

Slight agreement between visual assessment and TcB-defined need for follow-up (weighted κ=0.075), confirming that clinical observation alone is unreliable and objective measurement is essential

Additional research from a 2025 study in the Chinese Journal of Child Health Care demonstrated that "Internet+" remote jaundice monitoring significantly improved outcomes compared to traditional follow-up :

43% dropout rate in traditional follow-up versus only 11% in the remote monitoring group

First bilirubin measurement occurred at 4.0 days in remote group versus 8.0 days in traditional care—a critical difference for early intervention

38.6% hyperbilirubinemia rate in traditional follow-up versus 21.3% in remote monitoring

12.2% severe hyperbilirubinemia rate in traditional care versus only 3.4% with remote monitoring

Comprehensive Service Components

GoTo Telemed's Hyperbilirubinemia Follow-up Program delivers a complete, integrated solution for neonatal jaundice management:

Service Component Description
Nurse-Led Home Visits Specially trained pediatric nurses conduct home visits within 24-48 hours of hospital discharge, performing comprehensive newborn assessments and transcutaneous bilirubin measurements using FDA-cleared, hospital-grade TcB devices .
Real-Time TcB Screening Objective bilirubin measurements are obtained non-invasively, eliminating the pain and stress of heel sticks for newborns while providing accurate, actionable data for clinical decision-making .
Immediate Pediatric Teleconsultation TcB results are securely transmitted to GoTo Telemed's network of board-certified pediatricians and neonatologists, who provide real-time interpretation and management recommendations directly to families .
Phototherapy Threshold Monitoring Bilirubin levels are plotted against the 2022 American Academy of Pediatrics hour-specific phototherapy nomograms, which established higher, evidence-based treatment thresholds than previous guidelines, safely reducing unnecessary phototherapy .
Feeding Support and Lactation Consultation Recognizing that suboptimal intake contributes to jaundice, the program integrates lactation support to help breastfeeding mothers establish successful nursing, with recommendations to continue breastfeeding during treatment unless medically contraindicated .
Home Phototherapy Coordination For infants requiring phototherapy, GoTo Telemed coordinates home phototherapy services, enabling treatment in the family's residence rather than requiring hospital readmission—supported by updated clinical guidelines that endorse home phototherapy for appropriate candidates .
Automated Risk Stratification The platform applies AAP-endorsed risk factors—gestational age